Skip to main content
. 2000 Nov;122(2):285–290. doi: 10.1046/j.1365-2249.2000.01361.x

Fig. 1.

Fig. 1

Distribution of the IgA anti-cardiolipin antibody (aCL) levels of patients with acute Henoch–Schönlein purpura (HSP) (n = 21), of healthy controls (n = 20), and of juvenile rheumatoid arthritis (JRA) controls (n = 10). The difference of serum levels of IgA aCL between patients and both control groups was statistically significant.